TECHNOLOGY
QTempo -In Vitro Cardiotoxicity Assay System
QTempo is a new in vitro cardiotoxicity assay technology using human iPS/ES cell-derived cardiomyocytes.

Service Line-up

   Contract Assay Service
For customers who want to try the system or outsource the assay
Cardiotoxicity Assay Service
  • Basic service
  • Optional service
  •    Customer-Conducted Assay
    For customers who want to run the assay in-house
    Technical Tutorial
  • Technical know-how
  • Cardiomyocyte Products
  • Human iPS cell-derived cardiomyocyte kit
  • Measurement medium
  • 96 well electrode plate
  • Device
  • MEA-SYSTEM



  •    Contract Assay Service

    Cardiotoxicity Assay Service

    Basic service includes:
  • QT interval
  • Beat rate change
  • Optional service
  • QRS complex
  • Other services
        – Flexible customization to meet
            customer needs
  • Two cell options
  • Human iPS-derived cardiomyocyte
  • Human ES-derived cardiomyocyte

  • Turnaround time
    1 - 2 weeks from sample receipt
    QTempo assay allows analysis of the full range of ion channels. QTempo directly measures not only QT interval, but also a range of other cardiac action potential parameters (such as beat rate and the QRS complex). QTempo identifies compounds that affect Na, K and Ca ion channels and reflects their complex interactions. The cardiomyocyte clusters used in QTempo generate robust, consistent data over extended periods. This allows a wide variety of drug concentrations to be sequentially tested, increasing confidence in drug safety before further development.
    For more information, please contact info@infinitebio.com

       Home | About | Service | Products | Technologies | News & Event | Contact | Japanese